The biggest questions about ‘TrumpRx,’ the president’s plan to reduce drug costs | How Trump’s …


Explore the latest developments concerning The biggest questions.

The biggest questions about 'TrumpRx,' the president's plan to reduce drug costs

The Trump administration announced an effort to improve prescription drug prices for the American people, but it is unclear when, or to what extent, Americans will feel relief.

On May 12, Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” which directed the administration to work to reduce prescription drug costs by bringing them in line with what other nations pay. Yet the order’s broad strokes had few details about what this would look like.

On May 12, Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.”

With the unveiling of “TrumpRx” this week, Americans got some answers.

Will TrumpRx save me money on drugs or not?

Free speech is endangered; unbiased and trustworthy news is elusive. In a time of noise, confusion, and spin, we’re committed to clarity, truth, and depth — even when it’s hard.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

The president’s new plan to slash drug prices is “a splashy announcement without a lot of substance.”

President Donald Trump announced the latest addition to his personal branding empire this week: TrumpRx, a government website that claims it will offer deeply discounted drugs to many Americans. News of the website’s forthcoming launch was accompanied by an announcement from Pfizer that it would voluntarily reduce the prices it charges the Medicaid program.

Zeee 11.1V 80C 5200mAh 3S Lipo Battery with Deans Plug Hardcase Battery for RC Car Boat Truck Helicopter Airplane Racing Models

Check it out! »

The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.

For more news…

Exit mobile version
Skip to toolbar